The effects of silver, silicon-containing apatite towards bacteria and cell responses.
An integrated approach is proposed to incorporate silicon and silver into hydroxyapatite (HA) to enhance the biological response and reduce implant-related infection in bone substitutes. This study examined the responses of Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) bacteria to silver, silicon-containing apatite (Ag,Si-HA). Scanning electron microscopy images revealed significant reduction in adherence of S. aureus and E. coli bacteria on Ag,Si-HA as compared to HA. The antibacterial property of Ag,Si-HA was shown from a 7-log reduction of S. aureus population in the test solution and on the sample's surface as compared to HA at day 7. Rapid inhibition of the adherent bacteria suggested that the antibacterial action of Ag incorporated in Ag,Si-HA could be attributed to the Ag(+) ions on the crystal surface rather than the released Ag(+) ions. Presence of Ag may influence the biological response of HA and as such, the long-term interaction between human adipose-derived mesenchymal stem cells and Ag,Si-HA was evaluated in-vitro. An alamarBlue™ assay showed higher cell proliferation for Ag,Si-HA as compared to HA from day 3 onwards. Immunofluorescence staining revealed well-spread actin cytoskeletons on Ag,Si-HA. In addition, signs of extracellular matrix secretion and biomineralization were observed on Ag,Si-HA at day 14 onwards. Results demonstrated enhanced bone differentiation on Ag,Si-HA, as indicated by a higher level of protein expressions (type 1 collagen and osteocalcin) from day 14 to 21. Therefore, the incorporation of Ag and Si complement each other by endowing HA with antibacterial property, and concurrently promoting biological performance of the cells.
Department of Mechanical Engineering, National University of Singapore, 9 Engineering Drive 1, Singapore 117 576, Singapore.
Poon Nian
PN
Lim
Zhilong
Z
Shi
Koon Gee
KG
Neoh
Bow
B
Ho
Bee Yen
BY
Tay
Eng San
ES
Thian
D000273:Adipose Tissue / Q000187:drug effects / Q000382:microbiology; D000900:Anti-Bacterial Agents; D002454:Cell Differentiation; D024042:Collagen Type I / Q000378:metabolism; D003599:Cytoskeleton / Q000378:metabolism; D017886:Durapatite / Q000737:chemistry*; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007150:Immunohistochemistry; D007477:Ions; D008422:Materials Testing; D059630:Mesenchymal Stem Cells / Q000187:drug effects / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D008855:Microscopy, Electron, Scanning; D008856:Microscopy, Fluorescence; D015675:Osteocalcin / Q000378:metabolism; D012825:Silicon / Q000737:chemistry*; D012834:Silver / Q000737:chemistry*; D013211:Staphylococcus aureus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D024042:Collagen Type I; D007477:Ions; D015675:Osteocalcin; D012834:Silver; D017886:Durapatite; D012825:Silicon